- Home
- LBRT vs HRMY Comparison
LBRT vs HRMY Comparison
Compare LBRT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRT
- HRMY
- Stock Information
- Founded
- LBRT 2011
- HRMY 2017
- Country
- LBRT United States
- HRMY United States
- Employees
- LBRT N/A
- HRMY N/A
- Industry
- LBRT Oilfield Services/Equipment
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- LBRT Energy
- HRMY Health Care
- Exchange
- LBRT Nasdaq
- HRMY Nasdaq
- Market Cap
- LBRT 1.8B
- HRMY 1.5B
- IPO Year
- LBRT 2018
- HRMY 2020
- Fundamental
- Price
- LBRT $18.94
- HRMY $29.32
- Analyst Decision
- LBRT Buy
- HRMY Strong Buy
- Analyst Count
- LBRT 10
- HRMY 10
- Target Price
- LBRT $16.10
- HRMY $50.80
- AVG Volume (30 Days)
- LBRT 6.8M
- HRMY 820.5K
- Earning Date
- LBRT 10-16-2025
- HRMY 11-04-2025
- Dividend Yield
- LBRT 1.90%
- HRMY N/A
- EPS Growth
- LBRT N/A
- HRMY 58.41
- EPS
- LBRT 1.13
- HRMY 3.10
- Revenue
- LBRT $3,910,953,000.00
- HRMY $772,527,000.00
- Revenue This Year
- LBRT N/A
- HRMY $20.10
- Revenue Next Year
- LBRT N/A
- HRMY $16.50
- P/E Ratio
- LBRT $16.78
- HRMY $9.47
- Revenue Growth
- LBRT N/A
- HRMY 17.74
- 52 Week Low
- LBRT $9.50
- HRMY $25.52
- 52 Week High
- LBRT $23.58
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- LBRT 81.58
- HRMY 54.08
- Support Level
- LBRT $16.43
- HRMY $25.52
- Resistance Level
- LBRT $17.79
- HRMY $30.96
- Average True Range (ATR)
- LBRT 1.19
- HRMY 0.88
- MACD
- LBRT 0.44
- HRMY 0.69
- Stochastic Oscillator
- LBRT 96.61
- HRMY 69.85
About LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.